Diabetes & Metabolic Syndrome |
|
|
|
02/26/2008
- Addressing Metabolic Syndrome
ReferencesMetabolic syndrome is a convergence of cardiovascular disease (CVD) and diabetes risk factors—including being overweight/obese, high blood pressure, abnormal blood lipids and blood glucose abnormalities—connected by insulin resistance. While a relatively new term, and one that is still not officially recognized in some mainstream medical circles, its profile is rising with mainstream media attention.Researchers from the University of Minnesota recently ...
01/18/2008
- GENCINIA Aids Diabetics
ANAHEIM, Calif.— A proprietary extract of Coccinia cordifolia (syn. Coccinia indicia) may help patients with type 2 diabetes control their blood sugar and lower cholesterol (Diabetes Care. ePub ahead of print). In a double blind, placebo-controlled, randomized clinical trial conducted at the Institute of Population Health and Clinical Research, Bangalore, India, 60 patients with mild diabetes received 1 g/d ...
01/02/2008
- The Many Sides of Aloe
Aloe vera has long been used as a powerful healing plant in medicinal traditions in India, China and Africa, as well as an external and internal beauty aid for Egyptian royalty. But its market potential is still tremendous in the Western world.“Aloe has exponentially increased in functional uses over the past decade,” said Bill Neal, Eastern regional sales manager, Terry ...
12/11/2007
- Elements of Living Well ... With Diabetes
ReferencesIt takes more than “an apple a day” to live well in today’s hectic world. This is especially true for 7 percent of the population— 20.8 million children and adults living in the United States—who have diabetes, according to the latest study done by the American Diabetes Association (ADA).Diabetes is a chronic condition in which the body produces too little ...
10/23/2007
- Investment, Returns Mark Nutrition 21 2007 Results
PURCHASE, N.Y.— Nutrition21 (NASDAQ:NXXI) released its delayed fourth quarter (4Q) and fiscal year 2007 results over a month after announcing preliminary results on Aug. 13, saying it needed the additional time to complete a $17.75 million financing, as well as to meet year-end financial and Sarbanes-Oxley audit requirements. While 4Q revenues rose to $12.0 million from $2.5 million sold ...
|
|
|
|